CME program on world heart day on OCT / FFR .HCG-SUCHIRAYU hospital is proud to introduce Worlds Most advanced Optis mobile OCT(Optic Coherance Tomography) system with 3D reconstruction and Fly through mode with FFR/RFR services .

Interesting interactive well attended CME on Preoperative cardiovascular assessment and management of patients undergoing non-cardiac surgery arranged by APID

It was a pleasure being a  faculty for  AF Expert Conclave Meeting by Pfizer Wonderful discussion on NOAC use in Co-morbidities – Diabetes and CKD

Hypertension 2022 talk

Workshop on OCT by Dr Davinder Singh Chadha – one of the masters of OCT imaging . It was a pleasure and a great learning experience with Dr Chadha – a great teacher

It was a privilege to be invited to the conclave –“Meeting of Minds” arranged by GE healthcare with Dr Prof Luigi Badano a authority on 4D echo in the world , The agenda included interesting , interactive case discussions , debates and live hands-on with the most recent GE-VIVID E-95 Ultra edition 4D echocardiography . The program was attended by a select few cardiologists of India. #4DECHO , #GE #Genworks #GE-vivid E-95 ultra #GLS #Myocardialwork #GE-4Decho

Advisory Board Meeting on the latest updates in the treatment of Hypertension It was a wonderful discussion on the contemporary use of calcium channel blockers and the importance of beta blockers as antihypertensives in the management of young hypertensives .

HCG SUCHIRAYU Hospital was a part of Hybrid mode event “International Speaker Conclave – VENOUS THROMBOEMBOLISM BEYOUND LONG TERM MANAGAEMENT by DR David Jimenez . 10 select Hospitals from India were part of this meeting .

LAICON 2022 INTERNATIONAL CONFERENCE : It was a great privilege and pleasure to be part of LAICON international conference and deliver a lecture on STATINS IN HEART FAILURE. It was a great academic feast with the who’s who of lipidology and cardiology . Prof Dr B NORDESTGAARD has for more than 30 years of pioneering work in the pathogenesis, diagnosis and treatment of familial hypercholesterolemia, hyperlipidemia, atherosclerosis and cardiovascular disease, and has written extensively on these conditions. Prof. Børge G. Nordestgaard has published 660 original articles and 101 reviews, book chapters, consensus statements, & editorials. His H-index is 109 and he has published 78 highly cited papers. Original articles include publications in New England J Med, Lancet, Nature, Science, Nature Genetics, JAMA, British Medical Journal, , European Heart Journal , Circulation and JACC.

Heart & Diabetes. CONCLAVE Exploring New Avenues in Heart Failure Management & T2DM with CV Risk- An depth Multi-disciplinary and Multi-speciality discussion on SGLT2-Inhibitors.

CARDIO-VASCULAR CME - a wonderful Webinar arranged by ABOTT on OVERVIEW OF CARDIOVASCULAR DISEASES AND THROMBOEMBOLISM With special emphasis on the latest NOAC – It was indeed a among a fantastic discussion along with Dr Rajendra Prasad , Dr RAJESH and Dr Vimal vascular surgeons of Narayan Hrudyalaya and Manipal hospital.

Panel discussion on SGLT2 inhibitors organized by API Hubli-Dharwad Chapter in coordination with Microlabs – It was a wonderful discussion on the CARDIORENAL benefits of SGLT2 inhibitors .

Talk on Cangrelar – the latest P2Y12 inhibitor IV antiplatelet .

Prof Eugene Braunwald”s Greetings and message of appreciation for “LAICON 2022 INTERNATIONAL “. It is a big morale booster message for all of us Indians associated with Dyslipidemia management , in particular LAI 'a contribution to Indian community . It is a great privilege for me to be part of the organizing team of LAICON 2022 .

It was great learning and interaction in complex clinical cases by international speakers at the VIRTUAL GLOBAL PRECEPTORSHIP 2022 on Cardiac ATTR Amyloidosis – the latest in diagnosis and treatment. A very select few 10 cardiologists from INDIA were part of the meeting.

The ASCVD Atherosclerotic cardiovascular disease burden in India is very high . Inspite of use of lipid – cholesterol lowering drugs in patients with heart diseases – TARGET LEVELS AS PER LAI- LIPID ASSOCIATION OF INDIA is not achieved.

So in an effort to achieve these LDL target as per LAI guidelines in these patients we at SUCHIRAYU hospital under the guidance of LAI have implemented this unique method of printing the guidelines of ideal LDL levels in various risk groups and highlighting the patients present LDL values – whether achieved or not.

It was a pleasure to be a part of small focused group discussion with select few doctors of india on the concept of LOWER the LDL BETTER the clinical outcomes.

It was indeed a great pleasure to take part along with esteemed panel of select cardiologists of India as a Expert Advisor for the Pfizer Advisory Board meeting on NOAC’s.

It was a excellent programme and a pleasure to be a panelist in LAI talks . DR Raman Puri who is the founder chairman of LAI has undertaken the Herculean task of Propagating the LAI guidelines to all the Cardiologists and Physicians of India .

Moderated an excellently arranged CME on cardio-diabetes , had a wonderful scientific feast and discussion with all the physicians of north Karnataka . Torrent have done a great job and have gone an extra mile to arrange such a nice CME

Thrombosis be it Arterial or Venous always poses a emergency life threatening situation which needs prompt acute and long term management . Had an excellent discussion with the panel and the audience

(15-12-2021)

(22-11-2021)

Updates on SGLT2 inhibitors

CLOT BUSTER SERIES - PRESENTED A VERY INTERESTING CASE OF INTRACORONARY THROMBOLYSIS

facebook chat for the general public on Healthy heart

Hypertension management – Multifactorial approach Beta blockers as antihypertensives(Apart from its use in hypertension and associated comorbid compelling indications ) have been rediscovered especially in Young Indian hypertensives in whom the sympathetic activity is high . It was a pleasure interacting with my teacher and guru Prof DR V A Kothiwale Registrar and Vice principle KLE JNMC

Excellent insights provided by DR PROF LARS in establishing TAVR program in our hospital and a detailed step by step approach to the procedure .

HF cascade forum

It was pleasure to be a part of the GAME CHANGER series program arranged by NOVO NORDISK And it was a great discussion with DR GIRISH NAVASUNDI , DR VIVEKANADA G , and looking forward to use oral GLP1RA SEMAGLUTIDE in Diabetic patients with high ASCVD burden .

HF- GOLD CONNECT WEBINAR With the ACC 2021 heart failure update and ESC 2021 heart failure guidelines being published recently , it is the need of the hour to propagate this information to the practicing physicians and general practitioner .NOVARTIS have taken a great lead in doing so and arranging these series of webinars

Wonderful discussion on The Pathways to improve control oF Hypertension with DR Puneet Rastogi who is one of the ace cardiologists of Madhya Pradesh .

ADVISORY BOARD MEETING with some of the best specialists in india on Place in therapy of mineralocorticoid receptor antagonists in cardiology .The aim of which is To understand the clinical and practical uses of MRAs in Heart failure, Resistant hypertension, and other Cardiology indications

Webinar on Role of Rivaroxaban in cardiac patients , With the results COMPASS trial the role of rivaroxaban beyond stroke and systemic embolism prevention in AF , VTE treatment is extended to be used in stable coronary artery disease and peripheral arterial diseases. Well arranged webinar and it was pleasure to answer to all the queries of clinicians .

Discussion to conclusion debate on Anti thrombotic medications

Panelist in the expert conclave meeting on NOAC Fantastic in depth discussion on the current updates on usage of NAOC in various clinical setting - elderly , renal failure , GI bleeding , previous stroke . was attended by around 300 physicians of south india

Role of statins and Dual antiplatelets in cardiovascular risk reduction

HFpEF Focus group meeting under the moderatorship of DR P P Mohanan

Talk on Telmisartan

Webinar on COVID and HEART

It was indeed a pleasure to be presenting interesting cases and PCI complications and discussing with DR M S Hiremath who is the course director of KNOW THROMBOSIS series , DR Sreenivas and Dr jabir as moderators 

Role of Antiplatelets in the management of complex PCI.

First of its kind - A Webinar on NORPACE NEW - Norpace rediscovered.

Dr. Ameet participated as an advisor in the most coveted conference -MASTERCLASS INDIA - A VIRTUAL EVENT ON EXCELLENCE IN STROKE PREVENTION IN AF AND VTE MANAGEMENT with the world renowned DR PROF RENATO LOPES and other distinguished cardiologists of india. The virtual event was attended by almost 2000 doctors all over india.

A very attended and appreciated Live seminar on ROLE OF TICAGRELOR IN MEDICALLY MANAGED PATIENTS.

Heart Failure Academy 2020 - A Case based discussion by Dr. Ameet G. Sattur.

Dr. Ameet wonderfully discussied and rediscovered the ROLE OF BETA BLOCKERS IN THE MANAGEMENT OF CAD/CCS GUIDELINES AND BEYOND.

Dr. Ameet - Moderator for interesting case ACS case discussions in the ACS FORUM CME.

Expert meet on INDIAN CONSENSUS DEVELOPMENT IN RECENT TRENDS ON TICAGRELOR.

SCAI -Complex cases in Coronary Interventions - A virtual meet Exciting discussions on complex coronary interventions, complications and their management.

An Exclusive Webinar on Update In Antithrombotic Therapy.

Webinar on Approach to narrow and broad complex tachycardias

Clinical pearls on the management of a diabetic ACS with subsequent heart failure - Case based discussion

MEET THE EXPERT - Management of stroke prevention in atrial fibrillation and case study discussion - Presenting an interesting case of POST PTCA patient with GI bleeding.

Webinar on the most debated and important topic - management of STEMI in COVID pandemic.

Webinar on Approach to narrow and broad complex tachycardias

Dr. Ameet Sattur attended Online Zoom Meeting On "Cardio ColloQuium"

Dr. Ameet Sattur attended Online Zoom Meeting On "Heart Failure Conclave"

Dr. Ameet Sattur attended Web Conference On "Rivaroxaban: For The Management Of Arterial Thrombotic Disorders" Arranged By Anticoagulation Realm Forum.

Dr. Ameet Sattur Presented a interesting case on "Triple Trouble – Management of ACS and AF in a patient with GI bleeding". Was well attended by Cardiologists and physicians.

Dr. Ameet Sattur Attended Online CME On "Rivaroxaban: An Oral Factor Xa Inhibitor - A New Hope".

Telcom Study In Perspective - Achieving New "Normal" BP Goals With Combination Therapy, On Behalf Of TelCom Study Investigators.

Dr. Ameet leaded leaded the video conference with Dr. Vivekanand & Laveena.

Dr. Ameet leaded a closed group e-discussion on "Recent Advance In Management Of Heart Failure" Arranged By Cipla.

Dr. Ameet attended "Hypertension Continuum - A New Paradigm" an educational initiative by Dr. Reddy's

Dr. Ameet Was Invicted As A Speaker, by Pfizer for the topic "Relevance Of RWE's In Management Of AF & Secondary Stroke Prevention"

Dr. Astra Zeneca Invited Dr. Ameet for the Live Webinar on "Dynamics in Management Of ACS & HFrEF Patients"

Video Conference On Clinical Research & Biopharceutics

Dr. Ameet was invited for the Live Webinar On Pivotal Role Of Diuretics In Chronic Heart Failure & Resistant Hypertension."

Dr. Ameet was invited for the Digital Meeting to speak about "An Indian Specigic Discharge Checklist - Need Of An Hour."

Dr. Ameet spoke in the live seminar on "Role of Apixaban in AF & Covid-19 Treatment".

Dr. Ameet had a wonderful discussion on Heart failure management and answered to a lot of queries faced by physicians / general practitioners in starting and titrating the heart failure medications.

Talk on Role of ARB in reducing CV risk in hypertensive patients.

Another Antiarrythmic drug rediscovered (the other being disopyramide )- MEXILITINE IN MANAGEMENT OF VENTRICULAR ARRYTHMIA.

The Lipid Association of India LAI under the founder president DR RAMAN PURI is organising series of webinars all across india with the intention of stressing the need of having our own INDIAN LIPID GUIDELINES which the LAI are coming out by end of this year Since the incidence and severity of cardiovascular diseases is increasing exponentially in india it is imperative that all practising consultants endorse the Indian lipid guidelines.